Kendall Capital Management grew its holdings in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 45.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,212 shares of the biotechnology company’s stock after acquiring an additional 1,310 shares during the period. Kendall […]
United Therapeutics Co (NASDAQ:UTHR) EVP Sells $1,394,220 00 in Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
United Therapeutics (NASDAQ:UTHR – Get Free Report) was upgraded by analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a research note issued on Wednesday. A number of other brokerages have also recently issued reports on UTHR. Wedbush reissued an “outperform” rating and issued a $308.00 target price on shares of United […]
United Therapeutics Co. (NASDAQ:UTHR – Free Report) – Analysts at Leerink Partnrs lifted their Q3 2024 EPS estimates for United Therapeutics in a note issued to investors on Tuesday, March 26th. Leerink Partnrs analyst R. Ruiz now anticipates that the biotechnology company will earn $6.90 per share for the quarter, up from their prior estimate […]
Shares of United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) fell 3.4% during mid-day trading on Wednesday following insider selling activity. The company traded as low as $236.07 and last traded at $239.32. 136,394 shares traded hands during mid-day trading, a decline of 66% from the average session volume of 400,432 shares. The stock had […]